EBAY
47
3
PDCO
77
2
TROW
48
-6
ECL
62
5
AAP
32
-3
URBN
63
-7
FOXA
63
6
AXP
67
-3
DTE
45
-2
PEP
45
4
CHD
32
-2
VNO
54
-2
JCI
47
-4
UNH
42
-4
NWS
56
-4
NUE
43
-4
EXR
51
-2
HES
58
-3
NKE
40
-2
CME
58
2
EBAY
47
3
PDCO
77
2
TROW
48
-6
ECL
62
5
AAP
32
-3
URBN
63
-7
FOXA
63
6
AXP
67
-3
DTE
45
-2
PEP
45
4
CHD
32
-2
VNO
54
-2
JCI
47
-4
UNH
42
-4
NWS
56
-4
NUE
43
-4
EXR
51
-2
HES
58
-3
NKE
40
-2
CME
58
2
Financhill
Back

Ligand Pharmaceuticals Vs. Pieris Pharmaceuticals Industry Stock Comparison

Buy
51

LGND
Ligand Pharmaceuticals

Last Price:
113.46
Seasonality Move:
11.95%
Sell
31

PIRS
Pieris Pharmaceuticals

Last Price:
16.12
Seasonality Move:
4.02%
Buy
51
Ligand Pharmaceuticals (LGND) is a Buy

Is Ligand Pharmaceuticals a Buy, Sell or Hold?

  • The current Ligand Pharmaceuticals [LGND] share price is $113.51. The Score for LGND is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Pieris Pharmaceuticals (PIRS) is a Sell

Is Pieris Pharmaceuticals a Buy, Sell or Hold?

  • The current Pieris Pharmaceuticals [PIRS] share price is $16.13. The Score for PIRS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • PIRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LGND Stock Price Chart

What is Ligand Pharmaceuticals's stock price today?

  • The Ligand Pharmaceuticals share price today is $113.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.

PIRS Stock Price Chart

What is Pieris Pharmaceuticals's stock price today?

  • The Pieris Pharmaceuticals share price today is $16.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.

LGND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.35 Buy
Relative Strength Index (14 RSI): 44.78 Sell
Chaikin Money Flow: -103087 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.72 - 124.08) Sell
Bollinger Bands (100): (100.12 - 115.88) Buy

PIRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 45.81 Sell
Chaikin Money Flow: -3953 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.9 - 16.76) Sell
Bollinger Bands (100): (16.05 - 17.35) Sell

LGND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.76 Sell
20-day SMA: 118.38 Sell
50-day SMA: 113.22 Buy
200-day SMA: 94.18 Buy
8-day EMA: 118.77 Sell
20-day EMA: 118.5 Sell
50-day EMA: 114.17 Sell
200-day EMA: 97.83 Buy

PIRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.47 Sell
20-day SMA: 16.34 Sell
50-day SMA: 16.5 Sell
200-day SMA: 14.06 Buy
8-day EMA: 16.48 Sell
20-day EMA: 16.46 Sell
50-day EMA: 16.39 Sell
200-day EMA: 17.31 Sell

Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.58 per share.

Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.

Ligand Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pieris Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):